RSU grant lifts CAVA (NYSE: CAVA) insider Xenohristos’s holdings

Rhea-AI Filing Summary

Xenohristos Theodoros reported acquisition or exercise transactions in this Form 4 filing.

CAVA GROUP, INC. director and Chief Concept Officer Theodoros Xenohristos reported an equity award of 4,721 shares of common stock in the form of restricted stock units. These RSUs vest in three equal annual installments starting on January 24, 2027, contingent on continued service.

After this grant, he directly holds 336,926 shares of common stock, including unvested RSUs, and indirectly holds 16,000 shares through a trust, also including unvested RSUs.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Xenohristos Theodoros

Role Chief Concept Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,721	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 336,926 shares (Direct); Common Stock — 16,000 shares (Indirect, By Trust)

Footnotes (1)

1. Reflects a grant of restricted stock units ("RSUs"), which vest in three equal annual installments commencing on January 24, 2027, subject to the reporting person's continued service through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.0001 ("Common Stock") per share upon settlement. Includes unvested RSUs.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Xenohristos Theodoros

(Last) (First) (Middle)

C/O CAVA GROUP, INC.

14 RIDGE SQUARE NW, SUITE 500

(Street)

WASHINGTON DC 20016

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CAVA GROUP, INC. [ CAVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Concept Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/26/2026		A(1)		4,721	A	$0	336,926(2)	D
Common Stock								16,000	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects a grant of restricted stock units ("RSUs"), which vest in three equal annual installments commencing on January 24, 2027, subject to the reporting person's continued service through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.0001 ("Common Stock") per share upon settlement.

2. Includes unvested RSUs.

Remarks:

The reporting person states that this filing shall not be an admission that the reporting person is the beneficial owner of any of the securities reported herein as indirectly owned, and the reporting person disclaims beneficial ownership of such securities except to the extent of the reporting person's pecuniary interest therein.

	/s/ Amit Patel, as Attorney-in-Fact	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CAVA (CAVA) report for Theodoros Xenohristos?

CAVA reported that director and Chief Concept Officer Theodoros Xenohristos received a grant of 4,721 restricted stock units. Each RSU represents one share of CAVA common stock, awarded at no purchase price as part of his equity compensation.

How do the new RSUs for CAVA’s Theodoros Xenohristos vest over time?

The 4,721 restricted stock units granted to Theodoros Xenohristos vest in three equal annual installments starting January 24, 2027. Vesting is conditioned on his continued service with CAVA through each applicable vesting date.

What is Theodoros Xenohristos’s total direct CAVA (CAVA) shareholding after this grant?

Following the award, Theodoros Xenohristos directly holds 336,926 shares of CAVA common stock. This figure includes unvested restricted stock units that have been granted but will vest over time under the award terms.

What indirect CAVA (CAVA) holdings are reported for Theodoros Xenohristos?

In addition to his direct holdings, 16,000 CAVA common shares are reported as indirectly owned by Theodoros Xenohristos through a trust. The disclosure notes that this indirect position also includes unvested restricted stock units.

What does the transaction code on the CAVA (CAVA) Form 4 indicate?

The Form 4 uses transaction code “A,” indicating a grant, award, or other acquisition of CAVA common stock. This signals the shares were received as compensation rather than purchased in an open-market transaction for cash.

What type of security was granted to the CAVA (CAVA) insider on February 26, 2026?

On February 26, 2026, CAVA granted Theodoros Xenohristos restricted stock units tied to common stock. Each RSU represents a contingent right to receive one share of CAVA common stock upon settlement, subject to the vesting schedule.